A-Top Health Biotech Co., Ltd. (TPEX:7686)
Taiwan · Delayed Price · Currency is TWD 754.00
+4.00 (0.53%)
At close: Sep 24, 2026
A-Top Health Biotech Market Cap
A-Top Health Biotech has a market cap or net worth of 37.78 billion as of September 25, 2026.
Market Cap
37.78B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
754.00
ChartMarket Cap Chart
Since August 31, 2026, A-Top Health Biotech's market cap has increased from 26.06B to 37.78B, an increase of 45.00%. That is a compound annual growth rate of 28,353.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 37.78B | 0.53% |
| Sep 23, 2026 | 37.58B | -6.95% |
| Sep 22, 2026 | 40.39B | -2.42% |
| Sep 21, 2026 | 41.39B | 2.61% |
| Sep 18, 2026 | 40.34B | -7.15% |
| Sep 17, 2026 | 43.45B | -1.14% |
| Sep 16, 2026 | 43.95B | 0.92% |
| Sep 15, 2026 | 43.55B | 0.46% |
| Sep 14, 2026 | 43.35B | 11.90% |
| Sep 11, 2026 | 38.74B | -9.17% |
| Sep 10, 2026 | 42.64B | -4.38% |
| Sep 9, 2026 | 44.60B | -2.52% |
| Sep 8, 2026 | 45.75B | -7.12% |
| Sep 7, 2026 | 49.26B | 22.57% |
| Sep 4, 2026 | 40.19B | 33.67% |
| Sep 3, 2026 | 30.07B | 23.71% |
| Sep 2, 2026 | 24.30B | -3.96% |
| Sep 1, 2026 | 25.31B | -2.88% |
| Aug 31, 2026 | 26.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 58.57B |
| HanchorBio | 22.75B |
| Elixiron Immunotherapeutics (Cayman) Limited | 21.75B |
| Intelligene | 7.77B |
| Tripartite Therapeutics | 5.97B |
| Uwell Biopharma | 5.61B |
| Obigen Pharma | 5.36B |
| Pet Pharm Biotech | 3.09B |